India Juris advises on acquisition of Saitech Medicare

31 January 2010

Protech Biosystems “Protech” is India’s highly progressive health management company involved in research, manufacturing and marketing of branded and generic pharmaceutical formulations. Protech Biosystems exports to Russia & CIS countries, South East Asia, African countries, Latin American countries.

India Juris assisted the Protech in acquisition of majority stakes in Chandigarh, India based pharma company Saitech Medicare Pvt Ltd. The complex transaction involved due diligence, corporate law advise, advise on capital gain tax, shareholders agreements and various other side letters, transfer of registrations and approvals etc.

The transaction was successfully completed to the satisfaction of the client.

News & Deals

IJ advised the Investor in VAMA’s INR 22 Crore Pre-Series A funding round.

IJ acted as legal counsel to the Investor in Vama’s INR 22 Cr. funding round.

IJ advised Investor in $8,50,000 raise for H2 Carbon Zero

Publications

AML Issues & Compliances By Entities In GIFT City

Foreign Investment Landscape of India

Digital Transformation of Oil & Gas Industry

Newsletters

Redefining Standards: Singapore’s Regulatory Breakthrough in the Global Stablecoin Market

CASE ANALYSIS: COMPETITION COMMISSION OF INDIA V. KERALA FILM EXHIBITORS’ FEDERATION (2025)

India’s Energy Game: Navigating Russian Oil Amid Global Pressures